Madison, WI. January 30th, 2017.


Cellular Logistics is pleased to welcome Dr. Nancy Sweitzer to its Scientific Advisory Board. Sweitzer will advise the Company on clinical topics related to the development of the Company’s proprietary biomaterial. “We are thrilled to welcome Dr. Sweitzer to our team,” said Rick Soni, CEO of Cellular Logistics. “Her experience and knowledge in cardiac treatment and clinical trials will be invaluable to the Company’s product development.”


About the Company: Cellular Logistics is an early stage life science venture based on research at The Wisconsin Institute for Medical Research (WIMR) at the University of Wisconsin-Madison. The Company is commercializing an acellular biomaterial as a stand-alone therapeutic for cardiac and tissue vascularization applications. The material also provides a cell delivery mechanism for regenerative medicine therapeutics.